Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly-Anne Phillips

Showing results (11-20 of 143) with videos related to

Pageof 15
Sort By:
Breast (Edinburgh, Scotland)|June 13, 2016
Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfactionBrittany Ager, Phyllis Butow, Jesse Jansen, et al.
Brain and Cognition|June 25, 2005
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literatureMarina G Falleti, Antonietta Sanfilippo, Paul Maruff, et al.
The Medical Journal of Australia|August 22, 2021
The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutationsTamara Hettipathirana, Courtney Macdonald, Jing Xie, et al.
Breast (Edinburgh, Scotland)|August 29, 2021
Underutilisation of breast cancer prevention medication in AustraliaCourtney Macdonald, James A Chamberlain, Danielle Mazza, et al.
Gynecologic Oncology|April 22, 2004
A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancerDanny Rischin, Kelly-Anne Phillips, Michael Friedlander, et al.
Journal of the American Geriatrics Society|March 13, 2009
Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapyNancy N Baxter, Sara B Durham, Kelly-Anne Phillips, et al.
The Medical Journal of Australia|December 17, 2011
Medication to prevent breast cancer--too much to swallow?Sandra L Harvey, Jane E Francis, Amanda J McBride, et al.
British Journal of Cancer|June 22, 2018
Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situLouisa Lisa Lo, Roger Laughlin Milne, Yuyan Liao, et al.
Human Reproduction (Oxford, England)|July 1, 2020
The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservationAmy L Winship, Meaghan Griffiths, Carolina Lliberos Requesens, et al.
The Medical Journal of Australia|October 31, 2018
Preventing ovarian failure associated with chemotherapyWanyuan Cui, Catharyn Stern, Martha Hickey, et al.
Pageof 15

Showing results (11-20 of 143) with videos related to

Sort By:
Pageof 15
Breast (Edinburgh, Scotland)|June 13, 2016
Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfactionBrittany Ager, Phyllis Butow, Jesse Jansen, et al.
Brain and Cognition|June 25, 2005
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literatureMarina G Falleti, Antonietta Sanfilippo, Paul Maruff, et al.
The Medical Journal of Australia|August 22, 2021
The value of clinical breast examination in a breast cancer surveillance program for women with germline BRCA1 or BRCA2 mutationsTamara Hettipathirana, Courtney Macdonald, Jing Xie, et al.
Breast (Edinburgh, Scotland)|August 29, 2021
Underutilisation of breast cancer prevention medication in AustraliaCourtney Macdonald, James A Chamberlain, Danielle Mazza, et al.
Gynecologic Oncology|April 22, 2004
A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancerDanny Rischin, Kelly-Anne Phillips, Michael Friedlander, et al.
Journal of the American Geriatrics Society|March 13, 2009
Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapyNancy N Baxter, Sara B Durham, Kelly-Anne Phillips, et al.
The Medical Journal of Australia|December 17, 2011
Medication to prevent breast cancer--too much to swallow?Sandra L Harvey, Jane E Francis, Amanda J McBride, et al.
British Journal of Cancer|June 22, 2018
Validation of the IBIS breast cancer risk evaluator for women with lobular carcinoma in-situLouisa Lisa Lo, Roger Laughlin Milne, Yuyan Liao, et al.
Human Reproduction (Oxford, England)|July 1, 2020
The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservationAmy L Winship, Meaghan Griffiths, Carolina Lliberos Requesens, et al.
The Medical Journal of Australia|October 31, 2018
Preventing ovarian failure associated with chemotherapyWanyuan Cui, Catharyn Stern, Martha Hickey, et al.
Pageof 15